Dr. Olaleye Oginni is the Global Engagement & Partnership Director at Bioluminux Clinical Research, where he leads the development of strategic collaborations with sponsors, CROs, and healthcare organizations worldwide. A practicing General Practitioner, experienced Medical Director and Principal Investigator, he combines frontline clinical insight with a strong track record in governance, service transformation, and research leadership.

Dr. Oginni has extensive experience overseeing Primary Care and Integrated Clinical Services across London. As Medical Director of various healthcare providers and founder of ProMed Innovations, a research-focused clinical trial site, he has driven quality improvement, regulatory compliance, and innovative approaches to clinical delivery. His work includes strengthening patient safety systems, enhancing clinician performance, and embedding clinical governance frameworks across complex healthcare environments.

At Bioluminux, Dr. Oginni plays a central role in shaping global engagement strategies that expand the network’s international footprint and accelerate clinical trial delivery. By aligning operational excellence with sponsor priorities and advocating for diversity in research participation, he ensures partnerships deliver scientific rigour, inclusivity, and meaningful impact for patients.

At Bioluminux, Dr. Nnadozie plays a pivotal role in aligning sponsors, investigators, and operational teams. He engages early with sponsors to clarify objectives, ensure protocol feasibility, and address potential operational challenges. He oversees site readiness, drives study activation, and leads recruitment strategies that balance timely delivery with the highest standards of Good Clinical Practice (GCP).

He is committed to advancing Bioluminux’s mission to deliver ethical, innovative, and high-quality clinical research that improves outcomes for patients worldwide.